Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The absence of published half-life data is a direct consequence of how early this compound is in development: it has been used as a research tool to validate an enzyme target, not as a clinical candidate with a full pharmacokinetic package
BioSupply Trends Quarterly
Youll need to take extra care to avoid an infection
Insurance coverage remains unavailable for BPC-157 regardless of formulation, as the peptide lacks FDA approval for therapeutic use
US$ 21.64
US$ 21.52
US$ 25.73
US$ 28.96
US$ 24.45
US$ 24.51
US$ 21.99
US$ 22.12
US$ 23.84
